GM
74
5
NEM
40
3
FSLR
44
-2
RIG
43
-7
WYNN
36
-5
ILMN
32
-9
RRC
52
-6
EBAY
42
-2
FITB
60
-5
RSG
65
-3
DD
53
-6
CTAS
53
-3
MCD
52
-5
F
56
-3
GRMN
67
-4
PLD
45
-5
ADSK
66
-4
DFS
64
2
HRB
59
2
ESS
62
-3
GM
74
5
NEM
40
3
FSLR
44
-2
RIG
43
-7
WYNN
36
-5
ILMN
32
-9
RRC
52
-6
EBAY
42
-2
FITB
60
-5
RSG
65
-3
DD
53
-6
CTAS
53
-3
MCD
52
-5
F
56
-3
GRMN
67
-4
PLD
45
-5
ADSK
66
-4
DFS
64
2
HRB
59
2
ESS
62
-3
Financhill
Back

General Dynamics Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
41

GD
General Dynamics

Last Price:
288.01
Seasonality Move:
3.26%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
41
General Dynamics (GD) is a Sell

Is General Dynamics a Buy, Sell or Hold?

  • The current General Dynamics [GD] share price is $287.99. The Score for GD is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • GD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GD Stock Price Chart

What is General Dynamics's stock price today?

  • The General Dynamics share price today is $287.99
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GD is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

GD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 37.43 Sell
Chaikin Money Flow: -1005987 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (295.62 - 309.44) Sell
Bollinger Bands (100): (288.78 - 304.16) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

GD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 305.54 Sell
20-day SMA: 302.42 Sell
50-day SMA: 302.12 Sell
200-day SMA: 290.8 Sell
8-day EMA: 301.16 Sell
20-day EMA: 302.12 Sell
50-day EMA: 300.87 Sell
200-day EMA: 287.5 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

General Dynamics Earnings Growth & GD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.65 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.82 per share, and an increase next year of $2.16 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

General Dynamics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):